Member Info for PDMSPiper

Foreverfalling; On the 22nd June, only three days ago, you said there was “tremendous upside”.

You were right first time.

foreverfalling
Posted in: ODX
Posts: 1,585
Price: 49.00
No Opinion
RE: I believe22 Jun 2020 22:07
Both Avacta and ODX have some risk... and tremendous upside if they nail their propositions. Get over it“

10 million global cases.

9.5 million people naturally recovered their immune system developed antibodies.

From those 9.5 million recovered patients not one verified reinfection after 6 months.

I smell mass antibody testing and digital immunity certificates on phones.

Watch this space. DYOR.

We are six months in now and from all the millions and millions of infections all over the world these scientists have still not mentioned one global case of a reinfected patient in their letter.

If they had evidence of reinfected patients do t you think they’d be referencing them in their letter as evidence to back uo their claims?

Of course they would. 9.5 million cases globally, over 450,000 deaths. Not one reinfected patient on the news yet anywhere in the world. Six months in.

If there’s no immunity from Covid 19 after recovery then where are all the people who have had it twice?

Wouldn’t you think this group of scientists with all their medical contacts throughout the world would be bringing forward patients who have been reinfected to support their hypothesis.

There aren’t any. I’ll start believing antibodies don’t provide immunity when doubly infected patients start popping up everywhere. There aren’t any.

Lots of articles around today pre emptively bashing the big Government announcement shortly to be made.

If there were no immunity after infection then people would be popping up left right and centre in hotspots like Madrid, Paris and London saying they’ve had it twice. There aren’t any. The bbc love bashing Government policy but they haven’t found one person who’s had it twice.

Scientists normally say what they’re paid to say by who finds them and there is a lot of division around Antibody testing because of this and also a lot of secrecy because they don’t want general public ignoring any guidelines onc they’ve had it. Yet.

Vaccines are produced every year that give immunity via antibodies to various forms of flu. Here’s how they work....

https://www.nhs.uk/conditions/vaccinations/how-flu-vaccine-works/

Jog on dibs ya bitter *******.

You’re sore because you dumped your stock expecting to take the placing then got stiffed to the back of the queue and didn’t get your allocation.

Buy back in and swallow your pride or just fk off ya sad resentful ***. Thanks.

I fully agree TruthandTrust and in fact I have raised similar issues myself, always to just be attacked.

The simple fact is this: Avacta have had these Affirmers since 2015 and if you look back through the accounts they have burned £46Million during that time trying to produce a saleable product but without success.

Covid comes along and sudddenly Affirmers are a Viral game changer.

If that is the case then why, since 2015 and having spent £46Million, has no other anti viral application been developed?

Nothing for all the other family of Coronaviruses, nothing for Sars-Cov1, nothing for HIV, nothing for Ebola, nothing for SARS, nothing for Mers?

Why? Why 5 years and £46Million of failure but now it’s a viral game changer? I don’t get it.

I remain scheptical and unconvinced. I think it’s been hyped to raise money for the cancer work. Simple as that. We’ll see.

DYOR and lots of it!

Yes PL75, the appointment of Professor Mike Holmes to work with Abingdon, ODX and the UK RTC is great news. You’ve only posted half the story. Why not post his quote from the Abingdon tweet as well. Here’s what he said...

“Dr Mike Holmes commented, “The work Abingdon Health is undertaking with the UK-RTC is going to provide self-tests to the UK population on a scale never seen before"

That’s the UK RTC/Omega Diagnostics Antibody tests, to be provided to the UK population on a scale never been seen before.
Great news isn’t it. Happy to help.

Here’s the screenshot of the relevant portion of the Abingdon tweet.....

https://twitter.com/Joseph85079134/status/1275706191545581569?s=20

Lovely. :)

Probably design freeze with Abingdon press release at 10am and ODX intraday RNS.

The accuracy/specificity bar for mass testing is 98%, that’s why uk gov have rejected everything below that figure.

Cytiva are aiming for 90/95% max so even if they get a test out by the end of the year it won’t be accurate enough.

AVCT are into cancer research. These Covid tests are a sideline for them and have provided a means to an end in raising money.

Yellow Jersey PR employed to work their magic keeping investors interested. Seen it all before with YJ. Bunch of bull sheet artists.

DYOR.

Manufacturer of what?

There will be no Cytiva/AVCT Test even by Christmas. There’s min 6 months development work in that RNS and that’s *IF* they can make it accurate enough.

Yellow jersey will drag this test development jam tomorrow rubbish out for 12 months. They are past masters at it.

15,000 new cases recorded in India today. Much of the country was 43 degrees centigrade today, 32 and cloudy in Mumbai, much hotter elsewhere.

Strong uv sunlight doesn’t appear to be making much of a difference to transmission in India.

How is a virus that thrives in the human body at an average temperature of 36.5-37.5 degrees C, going to be killed off in the heat of an English summer day at 25-30 degrees max.

It’s a lot hotter inside our lungs than the average summer day in uk. It’s even rampant in India currently in temps of 40 degrees plus.

I’ll log into desktop later Mars. Probably only available on full site. Nothing on mobile app but entitlement and I’m out and about.
Ta.

The shares haven’t appeared on HL accounts.

All we have is a notification showing notice of entitlement.

We will receive an online application form to fill in over the next few days where we can notify that we want to take the entitlement or not and in addition, apply for any extra that may be available.

Everybody who held on 19th will be allocated their full 1:20 entitlement. Nobody will miss out but depending on the level of take up we might not get the extras we might apply for.

We will have to have cleared funds in the account to pay for everything we apply for by noon on 3rd July but will be only be told after this date if we have received the extra allocation.

Nobody has any open offer shares yet. There’s a process to go through.

This is a another political move by the ScotsNats Gov to create more divergence between Scottish policy and Westminster. The more they do things differently, the more ammo they can claim they have for independence.
Just like every single policy up to now that uk gov have implemented on easing lockdown, Sturgeon has announced something different, only to quietly follow a few weeks later.

Believe it or not this is extremely Bullish for Omega and the RTC. The Scots gov obviously have been briefed about upcoming Westminster announcements on the use of antibody testing and have decided to preemptively bash the policy by announcing divergence from it today.

I see this as heralding a big announcement re mass antibody testing from U.K. gov in coming days. Hold onto your hats. With the complex politics surrounding Covid policy across the uk, often all is not as it seems and there is a lot of smoke and mirrors and political posturing. Read between the lines.

GLA DYOR.

There was no embarrassment on my side PL. the question was not answered to any satisfaction and won’t be. The question was:

“Why did the gov form a consortium of lateral flow expert companies across the UK to produce andcantibody test but haven’t bothered to form one to produce a 98%+ comparable fast antigen test”

Your answer was that the gov didn’t bother because the “Avacta test” is coming. Lol. It made me chuckle as it was the expected deluded answer from the happy clappy congregation on that board.
I’ve even seen Avacta shareholders saying ODX is “overvalued”, said without irony and with a total lack of self awareness.
If Cytiva do, by a long shot, come up with a rapid antigen test using the Avacta affirmers then it is likely to be sub 90% accurate and all but useless. It’s will be no more than a Christmas cracker toy to keep shareholders interest but won’t be used in any mass screening applications as the bar for this is 98%+.

Let’s see what happens but I see a Train wreck approaching at Avacta. They’ll just keep spinning out the possibility of the test being here soon, next month, imminently, because that’s what Yellow Jersey PR are experts at. They’ve done it time and time again. They’ll just keep dangling more carrots in more interviews. Watch and learn.

I fully agree Avacta is overhyped with a massive unsustainable and unsupported market cap of £325Million +

Additionally I think it’s a bit suspicious and mysterious why Avacta have never used their affirmers to bind to any virus in the past, ever. Avacta have had these affirmers on trial since 2015 and in all that time have never come up with any viral application for any of the other Coronaviruses or HIV, Ebola, SARS Cov-1, Mers, nothing. I find that very suspicious.
Compare and contrast to ODX who are experts in this field and already have a world leading infectious disease test in visitect cd4 which is the only home based poc test capable of diagnosing hiv and also has mobile app connectivity. This is all bread and butter to omega. This is what they do and they have been quietly achieving and bringing more products to market while Avacta have been ramping future possibilities in order to raise that £45Million.
Other points to consider with AVCT: If you look at the books from 2017 and add up the annual losses, if coincidentally comes to £46Million. Near enough what they raised. True story.

Always stay away from or question any company that uses Turner Pope and Yellow Jersey PR. Their joint histories are full of very costly train wrecks.

I wouldn’t touch Avacta and anybody buying there needs to look very closely at what is in the RNS only and ignore all the Yellow Jersey PR bullsheet in the interviews they churn out. They rarely come to fruition.

DYOR.

Yes, all of the above.

CW, same happened to me on Tullow earlier this year. I had a limit but order on. They took it down lower than my order but it didn’t get filled.
HL sent me an email say that the order was cancelled as the price was not down there long enough to fill it.
No doubt if I’d had a stop loss set they would have found the time to take my stock though.
It’s a shocking racket of a system. They are supposed to keep an orderly market but there’s no money in that. Ha.

They just dropped it down to 42, -22% took out stop losses and back up. Fishing for stock. Interesting.